Business Angels Switzerland Revenue and Competitors
Employee Data
- Business Angels Switzerland has 27 Employees.
- Business Angels Switzerland grew their employee count by 13% last year.
Business Angels Switzerland's People
| Name | Title | Email/Phone |
|---|
Business Angels Switzerland Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.5M | 22 | 5% | $78.9M | N/A |
#2 | $35M | 16 | N/A | N/A | N/A |
#3 | $3.5M | 12 | 0% | N/A | N/A |
#4 | N/A | 36 | -3% | N/A | N/A |
#5 | $3.5M | 43 | 0% | N/A | N/A |
#6 | $7.5M | 10 | -55% | N/A | N/A |
#7 | N/A | 35 | -3% | N/A | N/A |
#8 | N/A | 10 | -9% | N/A | N/A |
#9 | $7.5M | 8 | -27% | N/A | N/A |
#10 | $1.7M | 56 | 0% | N/A | N/A |
What Is Business Angels Switzerland?
"Smart money for smart innovators" BAS, Business Angels Switzerland, is one of the oldest Business Angel Network in Switzerland. We're a not-for-profit organization with chapters in Suisse Romande and in Zürich. We organize 20 events and 60 startup presentations per year. They lead to more than 10 yearly investments. Our hundred members and the startups like the familiar and friendly atmosphere of our events. The member list is not disclosed.
keywords:N/A
N/A
Total Funding
27
Number of Employees
N/A
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Business Angels Switzerland News
... SWITZERLAND: Cimeio Therapeutics raises $50 million in Series A funding ... GERMANY: Business angels are investing a six-figure sum in...
Furthermore, the business angel has to participate in the new company's gains and losses. Investors must be natural persons living in the...
The Innosuisse Start-up Training in Business Growth and Business ... Let your co-founders and some angels invest at least CHF 20K each in...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.2M | 27 | -7% | N/A |
#2 | $4.6M | 27 | 0% | N/A |
#3 | $2.8M | 27 | 17% | $11.6M |
#4 | $2.5M | 27 | -32% | N/A |
#5 | $4.6M | 27 | -10% | N/A |